Join our investment network today and receive free stock alerts, market forecasts, and strategic investing insights updated throughout every trading day.
As of April 16, 2026, The Oncology Institute Inc. (TOI) is trading at $3.54, posting an intraday gain of 3.21% during regular market hours. This analysis examines key technical price levels for TOI, recent market context for the specialty oncology care sector, and potential short-term price scenarios that market participants may monitor. No recently released quarterly earnings data is available for TOI at the time of writing, so current price action is largely being driven by technical flows and
The (TOI) Stock: Valuation Metrics (+3.21%) 2026-04-16 - Bull Flag
TOI - Stock Analysis
3094 Comments
1766 Likes
1
Maizlee
Experienced Member
2 hours ago
US stock customer concentration analysis and revenue diversification assessment for business risk evaluation and investment safety assessment. We identify companies with too much dependency on single customers or concentrated revenue sources that could pose risks. We provide customer analysis, revenue diversification scoring, and concentration risk assessment for comprehensive coverage. Understand business risks with our comprehensive concentration analysis and diversification tools for safer investing.
👍 26
Reply
2
Jennaly
Consistent User
5 hours ago
I feel like there’s a whole group behind this.
👍 125
Reply
3
Shamaree
Insight Reader
1 day ago
Free US stock earnings trajectory analysis and revision trends to understand fundamental momentum. We track how analyst estimates have been changing over time to gauge improving or deteriorating expectations.
👍 270
Reply
4
Hanaya
Senior Contributor
1 day ago
I don’t understand, but I feel involved.
👍 235
Reply
5
Ivania
Senior Contributor
2 days ago
How do you even come up with this stuff? 🤯
👍 205
Reply
Disclaimer: Not investment advice. For informational purposes only. Past performance does not guarantee future results. Trading involves substantial risk of loss.